Key takeouts for me:
1. Large resource drives economies of scale, low operating cost
2. High quality product drives premium pricing
3. Premier location (regulatory, infrastructure, proximate markets).
4. Its all about China ...
This is a highly valuable, long term strategic asset.
Thanks again Thesi.
- Forums
- ASX - By Stock
- PLS
- Thesi’s soapbox questions for Ken Brinsden
Thesi’s soapbox questions for Ken Brinsden, page-21
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
|
|||||
Last
$3.00 |
Change
-0.020(0.66%) |
Mkt cap ! $9.045B |
Open | High | Low | Value | Volume |
$3.02 | $3.04 | $2.99 | $16.30M | 5.382M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
71 | 356952 | $2.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.00 | 97014 | 68 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
70 | 356675 | 2.990 |
54 | 480573 | 2.980 |
36 | 259186 | 2.970 |
44 | 299796 | 2.960 |
57 | 543052 | 2.950 |
Price($) | Vol. | No. |
---|---|---|
3.000 | 111643 | 67 |
3.010 | 297076 | 52 |
3.020 | 347759 | 33 |
3.030 | 340931 | 26 |
3.040 | 328193 | 25 |
Last trade - 12.00pm 16/07/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online